{"id":"W4412493533","doi":"10.1007/s12325-025-03258-9","title":"Real-World Evidence for Ixekizumab in the Treatment of Psoriasis, Psoriatic Arthritis, and Axial Spondyloarthritis: Systematic Literature Review 2022–2023","year":2025,"lang":"en","type":"review","venue":"Advances in Therapy","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"Eli Lilly (Canada)","funders":"Novartis Pharma; Samsung; LEO Pharma; Swedish Orphan Biovitrum; Chugai Pharmaceutical; Celltrion; UCB Pharma; Regeneron Pharmaceuticals; Baxalta; Biogen; Celgene; Cilag; Mylan; Gilead Sciences; Sanofi; Amgen; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Ixekizumab; Medicine; Secukinumab; Psoriatic arthritis; Psoriasis; Dermatology; Ustekinumab; Quality of life (healthcare); Internal medicine; Physical therapy; Adalimumab; Rheumatoid arthritis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01289815,0.00172241,0.008471758,0.01386219,0.0006476624,0.003365688,0.001868978,0.002078354,0.00658906],"category_scores_gemma":[0.0545318,0.001093657,0.01034606,0.01121774,0.001033955,0.002284146,0.001799796,0.00144192,0.0005485563],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003614277,"about_ca_system_score_gemma":0.01191037,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00643626,"about_ca_topic_score_gemma":0.01710082,"domain_scores_codex":[0.9859958,0.004947065,0.005815361,0.0008898486,0.002019509,0.0003324592],"domain_scores_gemma":[0.9437346,0.04083403,0.01044286,0.0006946468,0.00388342,0.0004103937],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0002226389,0.00001490314,0.0006652626,0.9634537,0.01354202,0.00006583454,0.00009046579,0.00007361161,0.0001239736,0.0001236923,0.0008454451,0.0207784],"study_design_scores_gemma":[0.0003623548,0.0002249901,0.003066652,0.8716553,0.111613,0.000279705,0.0001792964,0.00007539419,0.0001614638,0.0002347336,0.01211477,0.00003230856],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001027627,0.9972137,0.000148786,0.0003226175,0.0001259596,0.0002739732,0.0005688677,0.00000742975,0.0003110892],"genre_scores_gemma":[0.01862971,0.9782542,0.0007998013,0.0008922148,0.0001573502,0.0006139306,0.0005253235,0.000009173134,0.0001182613],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01386219,"threshold_uncertainty_score":0.06821281,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04201158268867548,"score_gpt":0.3994908874577577,"score_spread":0.3574793047690822,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}